The potential benefit of beta-blockers for the management of covid-19 protocol therapy-induced qt prolongation: A literature review

Publication Name : Scientia Pharmaceutica

DOI : 10.3390/scipharm88040055

Date : December 2020


Publication URL
https://www.scopus.com/record/display.uri?eid=2-s2.0-85096428135&origin=resultslist&sort=plf-f
Type
Journal
ISSN
00368709
Volume
88
Page
1-12